Complete Genomics' (GNOM +5.3%) restructuring and postponement of capacity expansion are...

|About: Complete Genomics, Inc. (GNOM)|By:, SA News Editor

Complete Genomics' (GNOM +5.3%) restructuring and postponement of capacity expansion are incremental positives for Illumina (ILMN +1.1%), observes Leerink Swann. The firm says v pricing in the whole human genome sequencing market could stabilize as a result of GNOM' actions.